Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Ecopipam Tablets to Study Tourette's Disorder in Children, Adolescents and Adults

ClinicalTrials.gov ID: NCT05615220

Public ClinicalTrials.gov record NCT05615220. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:35 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Placebo-Controlled, Randomized Withdrawal Study to Evaluate the Safety and Maintenance of Efficacy of Ecopipam in Children, Adolescents and Adults With Tourette's Disorder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This Phase 3 multicenter study evaluates the maintenance of efficacy, safety and tolerability of ecopipam tablets in children, adolescents and adults in the treatment of Tourette's Disorder (TD). The study includes an open-label period followed by a double-blind, placebo-controlled, randomized withdrawal period.

Study identification

NCT ID
NCT05615220
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Emalex Biosciences Inc.
Industry
Enrollment
216 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 31, 2023 (Actual)
Primary completion
Jan 13, 2025 (Actual)
Completion
Feb 4, 2025 (Actual)
Last update posted
Jun 12, 2026

2023 – 2025

United States locations

U.S. sites
56
U.S. states
21
U.S. cities
44
Facility City State ZIP Site status
Harmonex Neuroscience Research Dothan Alabama 36303 —
Arkansas Children's Hospital Little Rock Arkansas 72202 —
Advanced Research Center Anaheim California 92805 —
CenExel CIT-IE Bellflower California 90706 —
Cortica Site Network Glendale California 91203 —
Amnova Clinical Research Irvine California 92604 —
Cortica Site Network - San Rafael San Rafael California 94903 —
Syrentis Clinical Research Santa Ana California 92705 —
Yale School of Medicine New Haven Connecticut 06519 —
University of Florida Gainesville Florida 32608 —
NW FL Clinical Research Group, LLC Gulf Breeze Florida 32561 —
Research in Miami Inc Hialeah Florida 33013-3834 —
Emcrown Clinical Research Jensen Beach Florida 34957 —
University of Miami Miller School of Medicine Miami Florida 33136 —
Florida International Research Center Miami Florida 33173 —
Care Research Center Miami Florida 33175 —
Medical Research Group of Central Florida Orange City Florida 32763 —
APG Research LLC Orlando Florida 32803 —
University of South Florida St. Petersburg Florida 33701 —
Pediatric Epilepsy and Neurology Specialists Tampa Florida 33609-4181 —
Jedidiah Clinical Research Tampa Florida 33617 —
Pediatric Neurology, PA Winter Park Florida 32789 —
Advanced Discovery Research, LLC Atlanta Georgia 30318 —
Rare Disease Research, LLC Atlanta Georgia 30329 —
Atlanta Behavioral Research, LLC. Atlanta Georgia 30338 —
Lurie Children Hospital of Chicago Chicago Illinois 60611 —
1725 W. Harrison St., Suite 755 Chicago Illinois 60612 —
The University of Chicago Hospitals Chicago Illinois 60637-1447 —
Josephson-Wallack-Munshower Neurology Indianapolis Indiana 46256 —
Massachusetts General Hospital Boston Massachusetts 02114 —
Boston Children's Hospital Boston Massachusetts 02115 —
Umass Chan Medical School Worcester Massachusetts 01655 —
Michigan Clinical Research Institute PC Ann Arbor Michigan 48105 —
Neurobehavioral Medicine Group Bloomfield Hills Michigan 48302-1952 —
The Childrens Mercy Hospital Kansas City Missouri 64108 —
Midwest Research Group Saint Charles Missouri 63304 —
Washington University School of Medicine St Louis Missouri 63110 —
Alivation Research Lincoln Nebraska 68526 —
NYU Child Study Center New York New York 10016-5815 —
Mount Sinai School of Medicine New York New York 10029-6504 —
University of Rochester Rochester New York 14642 —
Stony Brook University Medical Center Stony Brook New York 11794 —
Wake Forest Baptist Medical Center - PPDS Winston-Salem North Carolina 27157-0001 —
Cincinnati Childrens Hospital Medical Center Cincinnati Ohio 45229-3026 —
North Star Medical Research, LLC Middleburg Heights Ohio 44130 —
Suburban Research Associates Media Pennsylvania 19063 —
Coastal Pediatric Research Charleston South Carolina 29414 —
Access Clinical Trials, Inc. Nashville Tennessee 37203-6502 —
Vanderbilt University Medical Center Nashville Tennessee 37232-7610 —
Baylor College of Medicine Houston Texas 77030 —
Texas Children's Hospital (TCH) Houston Texas 77030 —
The University of Texas Health Science Center at Houston Houston Texas 77030 —
Perceptive Pharma Research (PPR) Richmond Texas 77407 —
Road Runner Research Ltd. San Antonio Texas 78249-3539 —
Cedar Clinical Research Draper Utah 84020 —
Core Clinical Research Everett Washington 98201 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05615220, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 12, 2026 · Synced Nov 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05615220 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →